Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05898685 · ClinicalTrials.gov registry record · NA
Effect of a Single Session of Intermittent Hypoxia on Hematological Variables
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT05898685 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 54 participants.
The verdict
NCT05898685, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the effect of a single exposure of intermittent hypoxia on erythropoietin levels and hemoglobin mass in young adults, older adults and patients with type 2 diabetes.
Interventions
- BEHAVIORAL Intermittent hypoxia
- BEHAVIORAL Intermittent normoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2019-04-16 |
| Est. Completion | 2023-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05898685
The ClinicalTrials.gov registry entry for NCT05898685 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intermittent hypoxia is the first listed.
NCT05898685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05898685 about?
NCT05898685 is a clinical study titled "Effect of a Single Session of Intermittent Hypoxia on Hematological Variables". The purpose of the study is to determine the effect of a single exposure of intermittent hypoxia on erythropoietin levels and hemoglobin mass in young adults, older adults and patients with type 2 diabetes.
What is the current status of trial NCT05898685?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2019-04-16. Estimated completion is 2023-04-01.
What interventions are being tested in trial NCT05898685?
The interventions under investigation include: Intermittent hypoxia (BEHAVIORAL), Intermittent normoxia (BEHAVIORAL).
Who is sponsoring clinical trial NCT05898685?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.